학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 221건 | 목록
1~20
Academic Journal
Coombs CC; University of California Irvine, Irvine, CA, USA.; Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Brown JR; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Ghia P; Universita Vita-Salute San Raffaele Milano, Milano, Italy.; IRCCS Ospedale San Raffaele, Milano, Italy.; Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Patel K; Swedish Cancer Institute, Seattle, WA, USA.; Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, UK.; Tam CS; Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Seymour JF; Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.; Shah NN; Medical College of Wisconsin, Milwaukee, WI, USA.; Flinn I; Sarah Cannon Research Institute/Tennessee Oncology/OneOncology, Nashville, TN, USA.; Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, WA, Australia.; Ma S; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Rhodes JM; Rutgers Cancer Institute, New Brunswick, NJ, USA.; Izutsu K; National Cancer Center Hospital, Tokyo, Japan.; Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.; Wierda WG; MD Anderson Cancer Center, Houston, TX, USA.; Hess LM; Eli Lilly and Company, Indianapolis, IN, USA.; Bhandari NR; Eli Lilly and Company, Indianapolis, IN, USA.; Loubert A; Modus Outcomes, Lyon, France.; Abada PB; Eli Lilly and Company, Indianapolis, IN, USA.; Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New Year, NY, USA.
Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE
Editorial & Opinion
Roncaglia E; Computational Genomics Group, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.; Department of Biology, University of Padua, Padova, Italy.; Gaffo E; Department of Molecular Medicine, University of Padua, Padova, Italy.; Calabretto G; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy.; Fürstenau M; Department I of Internal Medicine, University of Cologne, Cologne, Germany.; Rogers KA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Baliakas P; Department of Immunology, Genetics and Pathology & Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Cui C; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Institutes of Health Science, Tianjin, China.; Miller C; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany.; Plevova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Oscier D; Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, UK.; Davis Z; Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, UK.; Nguyen-Khac F; Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Paris, France.; Rigolin GM; Hematology Section, Department of Medical Sciences, Arcispedale S. Anna, Azienda Ospedaliera-Universitaria, University of Ferrara, Ferrara, Italy.; Athanasiadou A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.; Baran-Marszak F; Laboratoire d'hématologie, Hôpital Avicenne, Assistance Publique- Hôpitaux de Paris, Paris, France.; Valiente A; Servicio de Genética, Hospital Universitario de Navarra, Pamplona, Spain.; Terol MJ; Servicio de Hematología y Oncología Médica, Hospital Clinico Universitario de Valencia, Valencia, Spain.; Abrisqueta P; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar, Hospital del Mar Research Institute, Barcelona, Spain.; Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar, Hospital del Mar Research Institute, Barcelona, Spain.; Martines A; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy.; Bonaldi L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy.; Mauro FR; Department of Translational and Precision Medicine, Hematology Unit, 'Sapienza' University, Rome, Italy.; Scarfò L; Medical School, Università Vita-Salute San Raffaele, Milano, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milano, Italy.; Chatzikonstantinou T; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.; Tausch E; Ulm University, Ulm, Germany.; Kreuzer KA; Department I of Internal Medicine, University of Cologne, Cologne, Germany.; Kater A; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.; Bosch F; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Doubek M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Panagiotidis P; First Department of Propaedeutic, University of Athens, Athens, Greece.; Kalashnikova O; Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, St. Petersburg, Russia.; Frezzato F; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy.; Ruocco V; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy.; Orsi S; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy.; Salek K; Department of Molecular Medicine, University of Padua, Padova, Italy.; Merlo R; Computational Genomics Group, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.; Department of Biology, University of Padua, Padova, Italy.; Caregari A; Computational Genomics Group, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.; Department of Biology, University of Padua, Padova, Italy.; Glogovitis I; Department of Molecular Medicine, University of Padua, Padova, Italy.; Cellini A; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy.; Angotzi F; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy.; Serafin A; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy.; Yi S; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Institutes of Health Science, Tianjin, China.; Eichhorst B; Department I of Internal Medicine, University of Cologne, Cologne, Germany.; Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Cuneo A; Hematology Section, Department of Medical Sciences, Arcispedale S. Anna, Azienda Ospedaliera-Universitaria, University of Ferrara, Ferrara, Italy.; Ghia P; Medical School, Università Vita-Salute San Raffaele, Milano, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milano, Italy.; Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.; Trentin L; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy.; Visentin A; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy. andrea.visentin@unipd.it.; Bortoluzzi S; Computational Genomics Group, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.
Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: In Process; MEDLINE
Academic Journal
Bhat SA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA. Electronic address: Seema.bhat@osumc.edu.; Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1977 (Electronic) Linking ISSN: 08898588 NLM ISO Abbreviation: Hematol Oncol Clin North Am Subsets: MEDLINE
Academic Journal
Patel K; Sarah Cannon Research Institute, Nashville, Tennessee, United States.; Vose JM; University of Nebraska Medical Center, Omaha, Nebraska, United States.; Nasta SD; University of Pennsylvania, Philadelphia, Pennsylvania, United States.; Brown JR; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Maddocks KJ; The Ohio State University, Columbus, Ohio, United States.; Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States.; Shah NN; Medical College of Wisconsin, Wauwatosa, Wisconsin, United States.; Fakhri B; Stanford University School of Medicine, Palo Alto, California, United States.; Tessoulin B; Nantes University Hospital, Nantes, France.; Ma S; Northwestern University, Chicago, Illinois, United States.; Jagadeesh D; Cleveland Clinic, Cleveland, Ohio, United States.; Lech-Maranda E; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Coombs CC; University of California Irvine, San Diego, California, United States.; Patel MR; Sarah Cannon Research Institute, Nashville, TN, United States.; Rhodes JM; Rutgers/CINJ, New Brunswick, New Jersey, United States.; Ujjani CS; Fred Hutchinson Cancer Center, Seattle, Washington, United States.; Hoffmann MS; University of Kansas Medical Center, Westwood, Kansas, United States.; Cheah CY; Sir Charles Gairdner Hospital, Perth, Australia.; Munir T; St James University Hospital, Leeds, United Kingdom.; Lewis DJ; Plymouth Hospitals NHS Trust, Plymouth, United Kingdom.; Scarfò L; Università Vita Salute San Raffaele, Milano, Italy.; Eyre TA; Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Alencar AJ; University of Miami Sylvester Comprehensive Cancer Center, Miami Beach, Florida, United States.; Cohen JB; Emory University, Atlanta, Georgia, United States.; Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Tsai DE; Eli Lilly and Company, Marco Island, Florida, United States.; Li M; Eli Lilly and Company, Indianapolis, Indiana, United States.; Bian Y; Eli Lilly and Company, Indianapolis, Indiana, United States.; Abada PB; Lilly, Indianapolis, Indiana, United States.; Balbas M; Eli Lilly and Company, Indianapolis, Indiana, United States.; Zinzani PLL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Italy.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Gordon BK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Muhowski EM; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.; Singh J; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.; Ravikrishnan J; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Peris-Cuesta A; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.; Diaz Rohena D; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.; Sanchez JR; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.; Thangavadivel S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Benrashid S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; He A; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Marr AR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Mitchell AD; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.; Urrutia JM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Misra S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Lai TH; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Yu L; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio.; Walker BR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Perry E; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Shukla SA; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.; Grieselhuber NR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Rogers KA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Lapalombella R; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Blachly JS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Kittai AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Bhat SA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.; Jain N; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.; Wierda WG; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.; Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio.; Niesman M; MingSight Pharmaceuticals Inc., San Diego, California.; Zhang K; MingSight Pharmaceuticals Inc., San Diego, California.; Sampath D; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.; Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Academic Journal
Brown JR; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Nguyen B; Eli Lilly and Company, Indianapolis, IN.; Desikan SP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.; Won H; Eli Lilly and Company, Indianapolis, IN.; Tantawy SI; Faculty of Medicine, Suez Canal University, Ismailia, Egypt.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; McNeely SC; Eli Lilly and Company, Indianapolis, IN.; Marella N; Eli Lilly and Company, Indianapolis, IN.; Randeria HS; Eli Lilly and Company, Indianapolis, IN.; Hanson LM; Eli Lilly and Company, Indianapolis, IN.; Parker A; Eli Lilly and Company, Indianapolis, IN.; Botelho SC; Eli Lilly and Company, Indianapolis, IN.; Woyach JA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Patel K; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA.; Tam CS; Department of Hematology, Alfred Health and Monash University, Melbourne, VIC, Australia.; Eyre TA; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom.; Cheah CY; Department of Hematology, Linear Clinical Research, Perth, WA, Australia.; Department of Hematology, Sir Charles Gairdner Hospital Perth, Perth, WA, Australia.; Shah NN; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Ghia P; Strategic Research Program on Chronic Lymphocytic Leukemia, Division of Experimental Oncology, Università Vita-Salute San Raffaele, Milan, Italy.; Strategic Research Program on Chronic Lymphocytic Leukemia, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.; Jurczak W; Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.; Balbas M; Eli Lilly and Company, Indianapolis, IN.; Nair B; Eli Lilly and Company, Indianapolis, IN.; Abada P; Eli Lilly and Company, Indianapolis, IN.; Wang C; Eli Lilly and Company, Indianapolis, IN.; Wang D; Eli Lilly and Company, Indianapolis, IN.; Roeker LE; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY.; Gandhi V; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Gordon BK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.; Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.; Grosicki S; Department of Cancer Prevention, Medical University of Silesia, Katowice, Poland.; Wrobel T; Department of Hematology, Cellular Therapies and Internal Medicine, Medical University of Wroclaw, Wroclaw, Poland.; Capra M; Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil.; Czyz J; Departament of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Torun, Poland.; Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.; Eom KS; Department of Hematology, Catholic Hematology Hospital, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South).; Panovská A; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.; Jurczak W; Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.; Laribi K; Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France.; Jacobasch L; Praxis of Haematology and Oncology, Dresden, Germany.; Baker R; Perth Blood Institute, Perth, WA, Australia.; Agajanian R; The Oncology Institute of Hope and Innovation, Whittier, CA.; Berkovits A; Inmunocel, Santiago, Chile.; Özcan M; Ankara University, School of Medicine, Ankara, Turkey.; Lepretre S; Centre de Lutte Contre le Cancer-Centre Henri Becquerel Normandie Rouen, Rouen, France.; Coombs CC; University of California Irvine, Irvine, CA.; Cramer P; Department of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.; Lewis KL; Division of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.; Division of Internal Medicine, Medical School, University of Western Australia, Perth, WA, Australia.; Hill M; Eli Lilly and Company, Indianapolis, IN.; Bao K; Eli Lilly and Company, Indianapolis, IN.; Bian Y; Eli Lilly and Company, Indianapolis, IN.; De Batista Ribeiro SR; Eli Lilly and Company, Indianapolis, IN.; Bhandari NR; Eli Lilly and Company, Indianapolis, IN.; Ruppert AS; Eli Lilly and Company, Indianapolis, IN.; Leow CC; Eli Lilly and Company, Indianapolis, IN.; Wierda WG; University of Texas MD Anderson Cancer Center, Houston, TX.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Visentin A; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy.; Gaffo E; Department of Molecular Medicine, University of Padua, Padova, Italy.; Fürstenau M; Department I of Internal Medicine, University of Cologne, Cologne, Germany.; Rogers KA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Panagiotis B; Department of Immunology, Genetics and Pathology & Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Cui C; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Tianjin Institutes of Health Science, Tianjin, China.; Miller C; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany.; Plevova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Oscier D; Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, United Kingdom.; Davis Z; Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, United Kingdom.; Nguyen-Khac F; Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris, France.; Roncaglia E; Computational Genomics Group, Department of Oncology, Surgery and Gastroenterology, University of Padua, Padova, Italy.; Department of Biology, University of Padua, Padova, Italy.; Rigolin GM; Hematology Section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.; Athanasiadou A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.; Baran-Marszak F; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France.; Valiente A; Servicio de Genética. Hospital Universitario de Navarra, Pamplona, Spain.; Terol MJ; Servicio de Hematología y Oncología Médica, Hospital Clinico Universitario de Valencia, Valencia, Spain.; Abrisqueta P; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain.; Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain.; Martines A; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy.; Bonaldi L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy.; Mauro FR; Department of Translational and Precision Medicine, Hematology unit, 'Sapienza' University, Rome, Italy.; Scarfò L; Medical School, Università Vita-Salute San Raffaele, Milano, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milano, Italy.; Chatzikonstantinou T; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.; Tausch E; Ulm University, Ulm, Germany.; Kreuzer KA; Department I of Internal Medicine, University of Cologne, Cologne, Germany.; Kater A; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, The Netherlands, Amsterdam, Netherlands.; Bosch F; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Doubek M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Panagiotidis P; First Department of Propaedeutic, University of Athens, Athens, Greece.; Kalashnikova O; Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, St. Petersburg, Russian Federation.; Frezzato F; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy.; Calabretto G; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy.; Ruocco V; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy.; Orsi S; Department of Molecular Medicine, University of Padua, Padova, Italy.; Cellini A; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy.; Angotzi F; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy.; Serafin A; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy.; Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Tianjin Institutes of Health Science, Tianjin, China.; Eichhorst B; Department I of Internal Medicine, University of Cologne, Cologne, Germany.; Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Cuneo A; Hematology Section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.; Ghia P; Medical School, Università Vita-Salute San Raffaele, Milano, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milano, Italy.; Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.; Trentin L; Hematology Unit, Department of Medicine, University of Padua, Padova, Italy. livio.trentin@unipd.it.; Bortoluzzi S; Computational Genomics Group, Department of Oncology, Surgery and Gastroenterology, University of Padua, Padova, Italy. stefania.bortoluzzi@unipd.it.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Editorial & Opinion
Alsouqi A; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Huang Y; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Christian B; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Reneau J; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Bhat SA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Brammer J; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Sawalha Y; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Baiocchi RA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Grever M; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Rogers KA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Reeser J; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Smith A; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Samorodnitsky E; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Roychowdhury S; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Maddocks K; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Woyach JA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Bond D; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: In Process; MEDLINE
Editorial & Opinion
Kittai AS; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adam.kittai@mssm.edu.; Huang Y; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Miller S; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Allan JN; Weill Cornell Medicine, New York, NY, USA.; Bhat SA; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Bond DA; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Brander DM; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Duke Cancer Institute, Durham, NC, USA.; Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.; Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.; Chong E; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Danilov AV; City of Hope National Medical Center, Duarte, CA, USA.; Ding W; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Dowling MR; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Dvorak-Kornaus K; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Freedman H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Hampel PJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Ho C; Division of Medical Oncology, University of Washington, Seattle, WA, USA.; Hwang SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Islam P; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Malakhov N; Weill Cornell Medicine, New York, NY, USA.; Matasar M; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA.; Miller C; Division of Pathology, The Ohio State University, Columbus, OH, USA.; Omer Z; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.; Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Parry E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Rabe KG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Raess PW; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA.; Rai M; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Roeker L; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Rhodes J; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA.; Rogers KA; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Saha A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.; Schade J; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA.; Scott HW; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; Shadman M; Division of Medical Oncology, University of Washington, Seattle, WA, USA.; Shouse G; City of Hope National Medical Center, Duarte, CA, USA.; Skarbnik A; Novant Health Cancer Institute, Lymphoma and CLL/SLL Program, Charlotte, NC, USA.; Spurgeon S; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Stephens DM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.; Thompson MC; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Thompson PA; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Wang Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Yano M; The Ohio State University College of Medicine, Columbus, OH, USA.; Woyach JA; Division of Hematology, The Ohio State University, Columbus, OH, USA.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: In Process; MEDLINE
Academic Journal
Alsouqi A; Division of Hematology and Oncology, University of Pittsburgh Medical Center- Hillman Cancer Center, Pittsburgh, PA.; Woyach JA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH. Electronic address: woyach.2@osu.edu.
Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Academic Journal
Sharman JP; Willamette Valley Cancer Institute and Research Center, Eugene, OR.; Egyed M; Department of Hematology, Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary.; Jurczak W; Department of Clinical Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Krakow, Poland.; Skarbnik A; Lymphoma and CLL Program, Novant Health Cancer Institute, Charlotte, NC.; Patel K; Swedish Medical Center, Seattle, WA.; Flinn IW; Tennessee Oncology, Nashville, TN.; Kamdar M; University of Colorado Cancer Center, Aurora, CO.; Munir T; Department of Haematology, Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.; Walewska R; Department of Haematology, Cancer Care, University Hospitals Dorset, Bournemouth, United Kingdom.; Hughes M; Tauranga Hospital, Tauranga, New Zealand.; Fogliatto LM; Department of Clinical Hematology, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.; Herishanu Y; Department of Hematology, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Banerji V; Departments of Internal Medicine and Biochemistry and Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba and Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, Canada.; Follows G; Department of Haematology, Addenbrooke's Hospital NHS Trust, Cambridge, United Kingdom.; Walker P; Department of Haematology, Peninsula Health and Peninsula Private Hospital, Frankston, Melbourne, Australia.; Ghia P; Università Vita-Salute San Raffaele, Milano, Italy.; IRCCS Ospedale San Raffaele, Milano, Italy.; Janssens A; Department of Hematology, University Hospitals Leuven, Leuven, Belgium.; Byrd JC; Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Ferrant E; Service d'Hématologie Clinique, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.; Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wierda WG; Department of Leukemia, AstraZeneca, New York, NY.; Wachira CW; AstraZeneca, South San Francisco, CA.; Suterwala BT; AstraZeneca, Gaithersburg, MD.; Miranda P; AstraZeneca, Gaithersburg, MD.; Munugalavadla V; AstraZeneca, South San Francisco, CA.; Wun CC; AstraZeneca, Gaithersburg, MD.; Woyach JA; Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Editorial & Opinion
Miller CR; Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Huang Y; Division of Hematology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Allan JN; Division of Hematology and Oncology, Weill Cornell Medicine, New York, New York, USA.; Bhat SA; Division of Hematology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Bond D; Division of Hematology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Brander D; Hematology/Oncology, Duke University, Durham, North Carolina, USA.; Byrd JC; Department of Internal Medicine, Division of Hematology-Oncology, University of Cincinnati, Cincinnati, Ohio, USA.; Chavez J; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA.; Chong E; University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, USA.; Danilov A; City of Hope National Medical Center, Duarte, California, USA.; Dowling MR; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; Dvorak-Kornaus K; Division of Hematology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Hampel PJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Ho C; Division of Medical Oncology, University of Washington, Seattle, Washington, USA.; Islam P; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Malakhov N; Division of Hematology and Oncology, Weill Cornell Medicine, New York, New York, USA.; Matasar M; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, New Jersey, USA.; Miller S; Division of Hematology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Parikh SA; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Rabe KG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.; Rhodes JM; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, New Jersey, USA.; Roeker LE; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Rogers KA; Division of Hematology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Saha A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA.; Skarbnik A; Novant Health Cancer Institute, Lymphoma and CLL Program, Charlotte, North Carolina, USA.; Scott H; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; Schade J; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, New Jersey, USA.; Shadman M; Division of Medical Oncology, University of Washington, Seattle, Washington, USA.; Shouse G; City of Hope National Medical Center, Duarte, California, USA.; Sojitra P; Department of Pathology, Rutgers Robert Wood Johnson Medical School, New Brunswick NJ, USA.; Stephens DM; Division of Hematology, University of North Carolina, Chapel Hill, North Carolina, USA.; Thompson MC; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Thompson PA; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; Wang Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Woyach JA; Division of Hematology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Yano M; College of Medicine, The Ohio State University, Columbus, Ohio, USA.; Omer Z; Department of Internal Medicine, Division of Hematology-Oncology, University of Cincinnati, Cincinnati, Ohio, USA.; Kittai AS; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: In Process; MEDLINE
Academic Journal
Blombery P; Clinical Haematology (Peter MacCallum Cancer Centre/Royal Melbourne Hospital), Melbourne, VIC, Australia. Piers.Blombery@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Piers.Blombery@petermac.org.; Collaborative Centre for Genomics Cancer Medicine, University of Melbourne, Melbourne, VIC, Australia. Piers.Blombery@petermac.org.; Chatzikonstantinou T; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Gerousi M; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.; Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Maggiore Charity Hospital, Novara, Italy.; Pospisilova S; Department of Internal Medicine, Hematology and Oncology, and Institute of Medical Genetics and Genomics, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Roberts AW; Clinical Haematology (Peter MacCallum Cancer Centre/Royal Melbourne Hospital), Melbourne, VIC, Australia.; Blood Cells and Blood Cancers Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.; Birkinshaw RW; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.; Structural Biology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Rossi D; Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Institute of Oncology Research, Laboratory of Experimental Hematology, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.; Scarfo L; Università Vita Salute San Raffaele, Milano, Italy.; Strategic Research Program on CLL, IRCCS Ospedale San Raffaele, Milano, Italy.; Seymour JF; Clinical Haematology (Peter MacCallum Cancer Centre/Royal Melbourne Hospital), Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Stilgenbauer S; Comprehensive Cancer Center Ulm (CCCU), Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; Wiestner A; NIH, National Heart Lung Blood Institute, Bethesda, MD, USA.; Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.; Brown JR; Department of Medical Oncology Dana-Farber Cancer Institute, Boston, MA, USA.; Ghia P; Università Vita Salute San Raffaele, Milano, Italy.; Strategic Research Program on CLL, IRCCS Ospedale San Raffaele, Milano, Italy.; Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Lamanna N; Herbert Irving Comprehensive Cancer Center Columbia University New York New York USA.; Tam CS; Alfred Health Melbourne Victoria Australia.; Central Clinical School Monash University Melbourne Victoria Australia.; Woyach JA; Division of Hematology The Ohio State University Comprehensive Cancer Center Columbus Ohio USA.; Alencar AJ; Sylvester Comprehensive Cancer Center University of Miami, Miller School of Medicine Miami Florida USA.; Palomba ML; Memorial Sloan Kettering Cancer Center New York New York USA.; Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli' Bologna Italy.; Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna Bologna Italy.; Flinn IW; Tennessee Oncology and OneOncology Nashville Tennessee USA.; Fakhri B; Division of Hematology and Oncology University of California San Francisco California USA.; Cohen JB; Winship Cancer Institute Emory University Atlanta Georgia USA.; Kontos A; Loxo@Lilly Indianapolis Indiana USA.; Konig H; Loxo@Lilly Indianapolis Indiana USA.; Ruppert AS; Eli Lilly and Company Indianapolis Indiana USA.; Chatterjee A; Loxo@Lilly Indianapolis Indiana USA.; Sizelove R; Eli Lilly and Company Indianapolis Indiana USA.; Compte L; Eli Lilly and Company Indianapolis Indiana USA.; Tsai DE; Loxo@Lilly Indianapolis Indiana USA.; Jurczak W; Department of Clinical Oncology Maria Sklodowska-Curie National Research Institute of Oncology Krakow Poland.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Academic Journal
Merchand-Reyes G; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.; Bull MF; College of Medicine, The Ohio State University, Columbus, OH, United States.; Santhanam R; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.; Valencia-Pena ML; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.; Murugesan RA; College of Medicine, The Ohio State University, Columbus, OH, United States.; Chordia A; College of Medicine, The Ohio State University, Columbus, OH, United States.; Mo XM; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, United States.; Robledo-Avila FH; Center for Microbial Pathogenesis, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.; Ruiz-Rosado JD; Kidney and Urinary Tract Center, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.; Division of Pediatric Nephrology and Hypertension, Nationwide Children's Hospital, Columbus, OH, United States.; Carson WE 3rd; Department of Surgery, The Ohio State University, Columbus, OH, United States.; Byrd JC; Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, United States.; Woyach JA; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.; Tridandapani S; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.; Butchar JP; Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Woyach JA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Woyach, JA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어